Drug profile · INN
halobetasol propionate
BRYHALI
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
halobetasol propionate (BRYHALI) is an FDA-listed pharmaceutical active ingredient. Route of administration: topical. Current US regulatory status: approved.
Key facts
INN halobetasol propionate
Brand BRYHALI
Route TOPICAL
Formulation UNKNOWN
Frequently asked questions
What is halobetasol propionate?
halobetasol propionate (BRYHALI) is an FDA-listed pharmaceutical active ingredient. Route of administration: topical. Current US regulatory status: approved.
What is the brand name for halobetasol propionate?
BRYHALI is a marketed brand name for halobetasol propionate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of halobetasol propionate?
halobetasol propionate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.